Final results of the HIV prevention study VOICE are published in NEJM
04-February-2015
Women who took part in VOICE study speak up about why they didn’t use the HIV prevention products being tested
29-October-2014
New results from VOICE associates tenofovir gel use with lower HSV-2 risk in women
28-October-2014
First Comparison Between Injectable Contraceptives DMPA and NET-EN Suggests Some Women Using DMPA Were at Higher Risk of Acquiring HIV
4-March-2014
Behavioral Measures of Product Use Didn’t Measure Up in VOICE HIV Prevention Trial, Report the Study’s Researchers
4-March-2014
Daily HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study
Mar 4, 2013
Microbicide Trials Network Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women
Nov 25, 2011
Microbicide Trials Network Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women
Sep 28, 2011
VOICE Study will Continue as it Considers What Action to Take After Results of Two Trials
Jul 13, 2011
HIV Prevention Trial Milestone: VOICE Study Completes Enrollment of 5,000 Women
Jun 6, 2011
Microbicide Trials Network Statement on the status of VOICE Study following announcement to close the FEM-PrEP trial
Apr 18, 2011
Trial shows ARVs can prevent HIV in men who have sex with men, making VOICE study in women more important than ever
Nov 23, 2010
Results of CAPRISA 004 a turning point for HIV prevention, say MTN researchers conducting VOICE
Jul 19, 2010
VOICE Study, a major HIV prevention trial for women, is launched in Zimbabwe
Sep 16, 2009
HIV prevention trial of ARV-based strategies to begin next month
Jul 20, 2009
